Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07NDK
|
|||
Former ID |
DIB011443
|
|||
Drug Name |
WAY-644
|
|||
Synonyms |
MMP-12 inhibitor (aortic abdominal aneurysm), Pfizer; MMP-12 inhibitor (aortic abdominal aneurysm), Wyeth
Click to Show/Hide
|
|||
Indication | Aortic aneurysm [ICD-11: BD50] | Investigative | [1] | |
Company |
Wyeth
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Matrix metalloproteinase-12 (MMP-12) | Target Info | Inhibitor | [1] |
NetPath Pathway | IL1 Signaling Pathway | |||
IL5 Signaling Pathway | ||||
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | |||
Reactome | Collagen degradation | |||
Degradation of the extracellular matrix | ||||
WikiPathways | TGF beta Signaling Pathway | |||
Degradation of collagen | ||||
Matrix Metalloproteinases |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1636). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.